The anti-cancer activities were speculated to involve the nuclear factor (erythroid-derived 2)-like 2 (NFE2L2)-mediated defense mechanism16 and the activation and translocation of NF-kappaB into the nucleus17. This evidence concerns the gene NFE2L2 and cancer.